Profiel
Momenteel bekleedt Joachim Friedrich Rudolf de functie van Chief Financial Officer & Director bij Cathay Biotech, Inc. en Chief Financial Officer bij Cathay Industrial Biotech Ltd. Dr. Rudolf was voorheen Chief Financial Officer bij HBM Partners AG en Director bij Ziemer Group AG. Dr. Rudolf behaalde een doctoraat en een graduaatsdiploma aan de Universiteit voor Toegepaste Wetenschappen van St. Gallen.
Actieve functies van Joachim Rudolf
| Bedrijven | Functie | Begin |
|---|---|---|
| CATHAY BIOTECH INC. | Directeur/Bestuurslid | 18-08-2019 |
Cathay Industrial Biotech Ltd.
Cathay Industrial Biotech Ltd. Chemicals: SpecialtyProcess Industries Manufactures chemicals, fuels and polymers | Financieel Directeur/CFO | - |
Eerdere bekende functies van Joachim Rudolf
| Bedrijven | Functie | Einde |
|---|---|---|
HBM Partners AG
HBM Partners AG Investment ManagersFinance HBM Partners invests in private and public companies located in India, China, North America and Europe. The firm focuses on biopharma, medtech, diagnostics and healthcare sectors. It provides financing for early, buyout and growth stage capital requirements with an investment size from USD 5 to 50 million. | Financieel Directeur/CFO | 01-11-2011 |
Ziemer Group AG
Ziemer Group AG Medical SpecialtiesHealth Technology Develops, manufactures, and markets diagnostic and surgical ophthalmic products | Corporate Officer/Principal | - |
Opleiding van Joachim Rudolf
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
HBM Partners AG
HBM Partners AG Investment ManagersFinance HBM Partners invests in private and public companies located in India, China, North America and Europe. The firm focuses on biopharma, medtech, diagnostics and healthcare sectors. It provides financing for early, buyout and growth stage capital requirements with an investment size from USD 5 to 50 million. | Finance |
Ziemer Group AG
Ziemer Group AG Medical SpecialtiesHealth Technology Develops, manufactures, and markets diagnostic and surgical ophthalmic products | Health Technology |
Cathay Industrial Biotech Ltd.
Cathay Industrial Biotech Ltd. Chemicals: SpecialtyProcess Industries Manufactures chemicals, fuels and polymers | Process Industries |
St. Gallen University of Applied Sciences
St. Gallen University of Applied Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cathay Biotech, Inc.
Cathay Biotech, Inc. Chemicals: SpecialtyProcess Industries Engages in research and development, manufacture & sale of dibasic acid, bio-based pentane diamine and polyamide products | Process Industries |
















